Cutaneous Hyperaesthesia in SARS-CoV-2 Infection: Rare but not Unique Clinical Manifestation
DOI:
https://doi.org/10.2340/00015555-3729Keywords:
SARS-CoV2 infection, COVID-19, neurological symptomsAbstract
Abstract is missing (Short communication)
Downloads
References
Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med 2020; 288: 192-206.
DOI: https://doi.org/10.1111/joim.13091
Mahase E. Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction. BMJ 2020; 368: m1036.
DOI: https://doi.org/10.1136/bmj.m1036
Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili SM, Bahreini E. A comprehensive review of COVID-19 characteristics. Biol Proced Online 2020; 22: 19.
DOI: https://doi.org/10.1186/s12575-020-00128-2
Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci 2020; 77: 8-12.
DOI: https://doi.org/10.1016/j.jocn.2020.05.017
Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020; 382: 2268-2270.
DOI: https://doi.org/10.1056/NEJMc2008597
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77: 683-690.
DOI: https://doi.org/10.1001/jamaneurol.2020.1127
Liguori C, Pierantozzi M, Spanetta M, Sarmati L, Cesta N, Iannetta M, et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behav Immun 2020; 88: 11-16.
DOI: https://doi.org/10.1016/j.bbi.2020.05.037
Merskey H, International Association for the Study of P, Task Force on T. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Seattle: IASP; 2002.
Yamada K, Kubota Y, Shimizu Y, Cui R, Mori Y, Okuno Y, et al. Sleep shortage is associated with postherpetic neuralgia development through hyperesthesia and acute pain intensity: a community-based prospective cohort study. Pain Pract 2019; 19: 476-483.
DOI: https://doi.org/10.1111/papr.12766
Krajewski PK, Szepietowski JC, Maj J. Cutaneous hyperesthesia: a novel manifestation of COVID-19. Brain Behav Immun 2020; 87: 188.
DOI: https://doi.org/10.1016/j.bbi.2020.05.064
Moutal A, Martin LF, Boinon L, Gomez K, Ran D, Zhou Y, et al. SARS-CoV-2 spike protein co-opts VEGF-A/neuropilin-1 receptor signaling to induce analgesia. Pain 2020 Oct 1 [Online ahead of print].
DOI: https://doi.org/10.1097/j.pain.0000000000002097
Weekes CD, Beeram M, Tolcher AW, Papadopoulos KP, Gore L, Hegde P, et al. A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors. Invest New Drugs 2014; 32: 653-660.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Piotr K. Krajewski, Joanna Maj, Jacek C. Szepietowski
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
